AtifShafqatMD
Oncology • Saint Louis, MOBreast Cancer, Genitourinary Oncology, Hematologic Oncology
Chief of Oncology Division, Chair Cancer Committee, President and Co-director Oncology Program.
Dr. Shafqat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3015 N Ballas Rd
Saint Louis, MO 63131Phone+1 314-996-5514Fax+1 314-996-5674
Summary
- Board certified in hematology and oncology. Specializes in Breast cancer, Testicular Cancer plus benign and malignant Hematology. Active participant in NCORP research program.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2005
Duke University HospitalResidency, Internal Medicine, 1995 - 1998
Aga Khan Medical CollegeClass of 1993
Certifications & Licensure
MO State Medical License 2005 - 2025
NC State Medical License 1998 - 2003- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Hematology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
- Fellow (FACP) American College of Physicians, 2007
Publications & Presentations
PubMed
- 1 citationsA Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11.Vered Stearns, Opeyemi A Jegede, Victor T-S Chang, Todd C Skaar, Jeffrey L Berenberg
Clinical Cancer Research. 2024-07-01 - 112 citationsAdjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trialHeather A. Wakelee, Suzanne E. Dahlberg, Steven M. Keller, William Tester, David R. Gandara
The Lancet. Oncology. 2017-12-01 - 6 citationsUnusual locations of involvement by malignancies: Case 1. Testicular plasmacytoma.Atif Shafqat, Moonahm Yum, Rafat Abanour, Kristen N. Ganjoo
Journal of Clinical Oncology. 2003-09-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
